User login
HMG-CoA reductase inhibitor therapy and the risk of venous thromboembolism in joint replacement surgery
Article Type
Changed
Tue, 10/02/2018 - 11:04
Display Headline
HMG-CoA reductase inhibitor therapy and the risk of venous thromboembolism in joint replacement surgery
Article PDF
Publications
Page Number
eS16
Article PDF
Article PDF
Page Number
eS16
Page Number
eS16
Publications
Publications
Article Type
Display Headline
HMG-CoA reductase inhibitor therapy and the risk of venous thromboembolism in joint replacement surgery
Display Headline
HMG-CoA reductase inhibitor therapy and the risk of venous thromboembolism in joint replacement surgery
Citation Override
Cleveland Clinic Journal of Medicine 2010 March;77(e-suppl 1):eS16
Disallow All Ads
Alternative CME
Consolidated Pubs: Do Not Show Source Publication Logo
Use ProPublica
Article PDF Media
Document